BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer.

Park, JaeIn; Jang, Jae-Hyun; Park, Geun-Soo; Chung, Yunro; You, Hye Jin; Kim, Jae-Hong

Park, JaeIn; Jang, Jae-Hyun; Park, Geun-Soo; Chung, Yunro; You, Hye Jin; Kim, Jae-Hong.

Afiliação

Park J; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Jang JH; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Park GS; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Chung Y; Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USA.
You HJ; Translational Research Branch, Division of Translational Science, National Cancer Center, Goyang 10408, Korea.
Kim JH; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.

BMB Rep ; 51(8): 373-377, 2018 Aug.

Article em En | MEDLINE | ID: mdl-29898809

Assuntos

Receptores do Leucotrieno B4/metabolismo; Neoplasias de Mama Triplo Negativas/metabolismo; Biomarcadores Tumorais/genética; Biomarcadores Tumorais/metabolismo; Feminino; Humanos; Metástase Neoplásica; Prognóstico; Receptores do Leucotrieno B4/genética; Neoplasias de Mama Triplo Negativas/genética

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores do Leucotrieno B4 / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: BMB Rep Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google